Cambrex Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Private

  • Employees
  • 2,000

Employees

  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 8

  • Investments
  • 12

Cambrex General Information

Description

Provider of drug substance, drug product and analytical services intended to serve the pharmaceutical industry. The company primarily supplies drug substance technologies and capabilities including biocatalysis, application programming interfaces, continuous flow, controlled substances, solid-state science, material characterization in addition to conventional dosage forms including oral solids, semi-solids and liquids and manufactures specialist dosage forms such as modified-release, fixed-dose combination, bi-layer tablets, sterile and non-sterile ointments, enabling pharma companies to accelerate the small molecule therapeutics.

Contact Information

Website
www.cambrex.com
Formerly Known As
CasChem
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • One Meadowlands Plaza
  • East Rutherford, NJ 07073
  • United States
+1 (201) 000-0000

Cambrex Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambrex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cambrex‘s full profile, request access.

Request a free trial

Cambrex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug substance, drug product and analytical services intended to serve the pharmaceutical industry. The comp
Pharmaceuticals
East Rutherford, NJ
2,000 As of 2024
00000
000000000 00000

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
000000000000000
Loures, Portugal
0000 As of 0000

00000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
000000000000000
Mumbai, India
00000 As of 0000
00000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cambrex Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hovione Corporation Loures, Portugal 0000
Cipla Corporation Mumbai, India 00000 000000&0
CordenPharma Private Equity-Backed Plankstadt, Germany 0000 000000000000
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
GSK Corporation Middlesex, United Kingdom 00000 000.00 000000000 000.00
You’re viewing 5 of 24 competitors. Get the full list »

Cambrex Executive Team (22)

Name Title Board Seat Contact Info
Thomas Loewald Chief Executive Officer
Matthew Bio Ph.D Chief Scientific Officer & President, Snapdragon Chemistry
Brandon Fincher President, Early Stage Development & Testing
Troy Player President of Drug Product and Early Stage Development & Testing Business Units
Robert Green Executive Vice President & Chief Financial Officer
You’re viewing 5 of 22 executive team members. Get the full list »

Cambrex Board Members (8)

Name Representing Role Since
00000 0'0000000 Permira Board Member 000 0000
00000 000000 Permira Chairman 000 0000
You’re viewing 2 of 8 board members. Get the full list »

Cambrex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambrex Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cambrex‘s full profile, request access.

Request a free trial

Cambrex Investments & Acquisitions (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Snapdragon Chemistry 18-Jan-2023 0000000000 BPO/Outsource Services 000000 00
Q1 Scientific 01-Jun-2022 0000000000 BPO/Outsource Services 000000 00
Avista Pharma 02-Jan-2019 0000000000 00000 Drug Discovery 000000 00
Halo Pharmaceutical 23-Jul-2018 0000000000 00000 Drug Discovery 000000 00
PharmaCore 07-Oct-2016 Merger/Acquisition 0000 Other Pharmaceuticals and Biotechnology 000000 00
You’re viewing 5 of 12 investments and acquisitions. Get the full list »

Cambrex Subsidiaries (3)

Company Name Industry Location Founded
Halo Pharmaceutical Canada Pharmaceuticals Mirabel, Canada 2018
Q1 Scientific BPO/Outsource Services Waterford, Ireland 0000
Cambrex Zenara Drug Discovery Hyderabad, India 0000
To view Cambrex’s complete subsidiaries history, request access »

Cambrex Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Halo Pharmaceutical 23-Jul-2018 000000000000000000 00000 Completed
  • 0000000
CoPharma (United States) 30-Oct-2001 Merger/Acquisition Completed
To view Cambrex’s complete exits history, request access »

Cambrex FAQs

  • When was Cambrex founded?

    Cambrex was founded in 1981.

  • Who is the CEO of Cambrex?

    Thomas Loewald is the CEO of Cambrex.

  • Where is Cambrex headquartered?

    Cambrex is headquartered in East Rutherford, NJ.

  • What is the size of Cambrex?

    Cambrex has 2,000 total employees.

  • What industry is Cambrex in?

    Cambrex’s primary industry is Pharmaceuticals.

  • Is Cambrex a private or public company?

    Cambrex is a Private company.

  • What is Cambrex’s current revenue?

    The current revenue for Cambrex is 00000.

  • How much funding has Cambrex raised over time?

    Cambrex has raised $336M.

  • Who are Cambrex’s investors?

    Permira and C2I Accelerator have invested in Cambrex.

  • Who are Cambrex’s competitors?

    Hovione, Cipla, CordenPharma, Novartis, and GSK are some of the 24 competitors of Cambrex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »